THROMBOPLASTIN AND ORAL ANTICOAGULANT CONTROL

Abstract

British Journal of HaematologyVolume 66, Issue 1 p. 1-4 Free Access THROMBOPLASTIN AND ORAL ANTICOAGULANT CONTROL S.M. Lewis, Corresponding Author S.M. Lewis Royal Postgraduate Medical School, Hammersmith Hospital, DuCane Road, London W12 OHSDr S. M. Lewis, Royal Postgraduate Medical School. Hammersmith Hospital, DuCane Road, London W12 0HS.Search for more papers by this author S.M. Lewis, Corresponding Author S.M. Lewis Royal Postgraduate Medical School, Hammersmith Hospital, DuCane Road, London W12 OHSDr S. M. Lewis, Royal Postgraduate Medical School. Hammersmith Hospital, DuCane Road, London W12 0HS.Search for more papers by this author First published: May 1987 https://doi.org/10.1111/j.1365-2141.1987.00385.x-i1Citations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References Bangham, D.R., Biggs, R., Brozovic, M. & Denson, K.W.E. (1973) Calibration of five different thromboplastins, using fresh and freeze-dried plasma. Thrombosis et Diathesis Haemorrhagica, 29, 228 – 239. Biggs, R. & Denson, K.V.E. (1967) Standardization of the one-stage prothrombin time for the control of anticoagulant therapy. British Medical journal i, 84 – 88. British Society for Haematology (1984) Guidelines on oral anticoagulant control: report prepared by BCSH Haemostasis and Thrombosis Task Force. Brozovic, M., Eder, G., Denson, K.W.E. & Loeliger, E.A. (1981) Requirements for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Technical Report Series, 658, 185 – 205. Hermans, J., Van den Besselaar, A.M.H.P., Loeliger, E.A. & Van der Velde, E.A. (1983) A collaborative calibration study of reference materials for thromboplastins. Thrombosis and Haemostasis, 50, 712 – 717. Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent. M., Turpie, A.G.G., McLoughlin, D., Dodd, P., Thomas, M., Raskob. G. & Ockleford, P. (1982) Different intensities of oral anticoagulation therapy in the treatment of proximal-vein thrombosis. New England Journal of Medicine, 307, 1676 – 1681. International Committee on Thrombosis and Haemostasis-International Committee for Standardization in Haematology (1979) Prothrombin time standardization: Report of the Expert Panel on Oral Anticoagulant Control. Thrombosis and Haemostasis, 42, 1073 – 1114. International Committee for Standardization in Haematology-International Committee on Thrombosis and Haemostasis (1985) Recommendations for reporting prothrombin time in oral anticoagulant control. Journal of Clinical Pathology, 38, 133 – 134. Kirkwood, T.B.L. (1983) Calibration of reference thromboplastins and standardization of the prothrombin time ratio. Thrombosis and Haemostasis, 49, 238 – 244. Kirkwood, T.B.L. & Lewis, S.M. (1983) Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. WHO Technical Report Series, 687, 81 – 99. Koepke, J.A. & Gilmer, P.R. & Triplett, D. (1977) The prediction of prothrombin time system performance using secondary standards. American Journal of Clinical Pathology, 68, 191 – 194. Loeliger, E.A. & Lewis, S.M. (1982) Progress in laboratory control of oral anticoagulants. Lancet, ii, 318 – 320. Loeliger, E.A., van den Besselaar, A.M.H.P. & Broekmans, A.W. (1983) Intensity of oral anticoagulation in patients monitored with various thromboplastins. New England Journal of Medicine, 308, 1228 – 1229. Loeliger, E.A., van den Besselaar, A.M.H.P. & Lewis, S.M. (1985) Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thrombosis and Haemostasis, 53, 148 – 154. Poller, L. (1964) Standardization of anticoagulant treatment: the Manchester Regional Thromboplastin Scheme. Lancet, ii, 565 – 566. Poller, L. (1967) A National standard for anticoagulant therapy. The Manchester Comparative reagent. Lancet, i, 491 – 493. Poller, L. (1970) The British Comparative thromboplastin: the use of the National thromboplastin reagent for uniformity of laboratory control of oral anticoagulants and expression of results. Association of Clinical Pathologists. Broadsheet No. 71. Poller, L. (1983) Standardization of oral anticoagulant treatment. British Medical Journal, 287, 1379. Poller, L. (1986) Laboratory control of anticoagulant therapy. Seminars in Thrombosis and Hemostasis 12, 13 – 19. Poller, L. & Taberner, D.A. (1982) Dosage and control of oral anticoagulants: an international survey. British Journal of Haematology, 51, 479 – 485. WHO Expert Committee on Biological Standardization (1977a) Twenty-eighth Report. WHO Technical Report Series, 610, 14. WHO Expert Committee on Biological Standardization (1977b) Thirtieth Report. WHO Technical Report Series, 638, 23. WHO Working Group on the Standardization of Human Blood Products and Related Substances (1977c) Standardization in the control of anticoagulation (oral). WHO Technical Report Series, 610. 45 – 51. WHO Expert Committee on Biological Standardization (1983) Thirty third Report. WHO Technical Report Series, 687, 25. WHO Expert Committee on Biological Standardization (1984a) Thirty fourth Report. WHO Technical Report Series, 700, 18 – 19. WHO (1984b) Biological substances: International Standards, Reference Preparations, and Reference Reagents. World Health Organization. Geneva . Citing Literature Volume66, Issue1May 1987Pages 1-4 ReferencesRelatedInformation